News Column

Healthways Reports Second-Quarter Results

July 23, 2014

Revenues of $180.6 Million Increase 11.3% from Second Quarter Last Year

Affirms Financial Guidance for 2014

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Ben R. Leedle, Jr., president and chief executive officer of Healthways (NASDAQ: HWAY), today announced financial results for the second quarter and six months ended June 30, 2014. For the quarter, revenues increased 11.3% to $180.6 million from $162.3 million for the second quarter of 2013. Net loss for the second quarter of 2014 was $0.5 million, or $0.01 per share, compared with a net loss of $1.1 million, or $0.03 per share, for the second quarter of 2013. Adjusted net income for the second quarter of 2014 was $0.01 per diluted share, which excludes non-cash interest expense of $0.03 per diluted share, compared with adjusted net loss of $0.03 per share for the second quarter of 2013. (See pages 9 and 10 for a reconciliation of non-GAAP financial measures.)

For the first six months of 2014, revenues were $357.4 million, up 9.1% from $327.4 million for the first half of 2013. Net loss for the first six months of 2014 was $10.1 million, or $0.29 per share, compared with a net loss of $5.1 million, or $0.15 per share, for the same period in 2013. Adjusted net loss for the first six months of 2014 was $0.06 per share, which excludes a contract dispute settlement charge of $0.17 per share and non-cash interest expense of $0.06 per share, compared with adjusted net loss of $0.15 per share for the first six months of 2013.

“Our financial results for the second quarter were consistent with our expectations,” commented Leedle. “We have now generated four consecutive quarters of sequential-quarter revenue growth. Our revenue growth of 9% for the first half of the year generated better margins, leading to a 16% increase in adjusted EBITDA.

“Our net cash flows from operations for the quarter were $10.2 million, while second-quarter capital expenditures were $10.4 million. Our ratio of total debt to EBITDA, as calculated under our credit agreement, improved to 3.9 at the end of the quarter from 4.2 at the end of the first quarter of 2014.”

Broad Market Adoption of Well-Being Improvement

“Our business development momentum continued at a strong pace during the second quarter. Our contract pipeline expanded, reflecting growing market demand for population health services and, in particular, our Well-Being Improvement SolutionTM,” Leedle said. “During the quarter, we signed 19 contracts, including three contracts with new customers, three contract expansions and thirteen contract extensions. These contracts were broad-based among our four domestic customer markets: commercial health plans; Medicare Advantage plans; large employers; and health systems, hospitals and physicians.

“One of these second-quarter contracts was a large multi-year renewal of our SilverSneakers® Fitness program with Highmark, Inc., extending our 10-year relationship. In addition, we announced an expansion of our 13-year relationship with the Hawaii Medical Service Association (HMSA) to make the Dr. Dean Ornish Lifestyle Management program (Ornish Program) available to HMSA’s eligible commercial and government health plan members. HMSA continues to be a health plan market leader as evidenced by their decision to expand the eligibility criteria for the Ornish Program beyond coronary artery disease to include diabetes and multiple high-risk health issues.

“We have a substantial and active pipeline of potential contracts with new and existing customers across both our domestic and international markets. Of particular note, our Ornish Program and our acute to post-acute Care Transitions SolutionTM (CTS) are resonating with health plans and health systems. These solutions are seen as driving important value in today’s fee-for-service reimbursement, as well as providing important quality and cost management impact for value-based payment arrangements. The Ornish Program and CTS afford a “now and later” value proposition that provides flexibility for our customers to benefit no matter the reimbursement method, mix and rate of change that they are facing in their respective markets. These programs are affording us the opportunity to establish relationships with new customers now and expand the scope of our services over time.”

2014 Financial Guidance

Key Elements (See pages 9 and 10 for a reconciliation of non-GAAP financial measures):

  • Guidance for 2014 revenues remains in a range of $730 million to $760 million.
  • Guidance for 2014 adjusted EBITDA margin remains in a range of 10.5% to 11.5%.
  • Earnings guidance:
             

    Guidance

    Year Ending

    December 31,

    2014

    Adjusted net earnings per diluted share $   0.11 – 0.26
    Non-cash interest expense per share (0.11 )
    Settlement charge per share     (0.17 )
    Net (loss) per share $  

    (0.17)-(0.02

    )

     


    Healthways expects that profit margins will improve in the second half of 2014 compared with the first half of the year, primarily due to continued revenue growth, including recognition of performance-based fees. Healthways also continues to expect operating cash flow for the full year of $75 million to $85 million, total capital expenditures of $40 million to $45 million and improvement in the ratio of total debt to EBITDA, as calculated under its credit agreement.

    Summary

    Leedle concluded, “Our financial results for the first half of 2014 support our growth expectations for the year. The signing and launch of new business, particularly our Ornish Program, coupled with the recognition of performance-based fees, which are likely to be more weighted to the fourth quarter, will be critical elements to our second-half results. We expect that continued execution in the second half will enable the achievement of our guidance for the full year, and as a result today we have affirmed our financial guidance.”

    Conference Call

    Healthways will hold a conference call to discuss this release today at 5:00 p.m. Eastern Time. Investors will have the opportunity to listen to the conference call live over the Internet by going to www.healthways.com and clicking Investors at least 15 minutes early to register, download and install any necessary audio software. Presentation materials related to the conference call may also be accessed by going to www.healthways.com and clicking Investors. For those who cannot listen to the live broadcast, a telephonic replay will be available for one week at 719-457-0820, code 6919986, and the replay will also be available on the Company’s web site for the next 12 months.

    Safe Harbor Provisions

    This press release contains forward-looking statements, including our guidance and financial expectations for future periods, which are based upon current expectations, involve a number of risks and uncertainties and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief or expectations of the Company, including, without limitation, all statements regarding the Company’s future earnings and results of operations. Those forward-looking statements are subject to the finalization of the Company’s quarterly and year-end financial accounting procedures and may be affected by certain risks and uncertainties, including, but not limited to:

  • the effectiveness of management’s strategies and decisions;
  • the Company’s ability to sign and implement new contracts for our solutions;
  • the Company’s ability to accurately forecast the costs required to successfully implement new contracts;
  • the Company’s ability to accurately forecast the costs necessary to integrate new or acquired businesses, services (including outsourced services) or technologies into the Company’s business;
  • the Company’s ability to achieve estimated annualized revenue in backlog in the manner and within the timeframe we expect, which is based on certain estimates regarding the implementation of our services;
  • the Company’s ability to anticipate change and respond to emerging trends in the domestic and international markets for healthcare and the impact of the same on demand for the Company’s services;
  • the Company’s ability to implement its integrated data and technology solutions platform within the required time frame and expected cost estimates and to develop and enhance this platform and/or other technologies to meet evolving customer and market needs;
  • the Company’s ability to renew and/or maintain contracts with its customers under existing terms or restructure these contracts on terms that would not have a material negative impact on the Company’s results of operations;
  • the Company’s ability to accurately forecast the Company’s revenues, margins, earnings and net income, as well as any potential charges that the Company may incur as a result of changes in its business;
  • the Company’s ability to accurately forecast performance and the timing of revenue recognition under the terms of its customer contracts ahead of data collection and reconciliation;
  • the Company’s ability to accurately forecast enrollment and participation rates in services and programs offered within the Company’s contracts;
  • the risks associated with deriving a significant concentration of revenues from a limited number of customers;
  • the risks associated with foreign currency exchange rate fluctuations;
  • the ability of the Company’s customers to provide timely and accurate data that is essential to the operation and measurement of the Company’s performance;
  • the Company’s ability to achieve the contractually required cost savings and clinical outcomes improvements and reach mutual agreement with customers with respect to cost savings, or to achieve such savings and improvements within the time frames it contemplates;
  • the risks associated with changes in macroeconomic conditions;
  • the risks associated with data privacy or security breaches, computer hacking, network penetration and other illegal intrusions of our information systems or those of third-party vendors or other service providers, which may result in unauthorized access by third parties to customer, employee or Company information or patient health information and lead to enforcement actions, fines and other litigation against the Company;
  • the Company’s ability to effectively compete against other entities, whose financial, research, staff, and marketing resources may exceed our resources;
  • the Company’s ability to service its debt and remain in compliance with its debt covenants;
  • counterparty risk associated with our interest rate swap agreements and foreign currency exchanged contracts;
  • the impact of litigation involving the Company and/or its subsidiaries;
  • the impact of future state, federal and international legislation and regulations applicable to the Company’s business, including the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 on the Company’s operations and/or demand for its services; and
  • other risks detailed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013, and other filings with the Securities and Exchange Commission.

    The Company undertakes no obligation to update or revise any such forward-looking statements.

    About Healthways

    Healthways is the largest independent global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the Company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities. We provide highly specific and personalized support for each individual and their team of experts to optimize each participant’s health and productivity and to reduce health-related costs. Results are achieved by addressing longitudinal health risks and care needs of everyone in a given population. The Company has scaled its proprietary technology infrastructure and delivery capabilities developed over 30 years and now serves approximately 68 million people on four continents. Learn more at www.healthways.com.

                   

    HEALTHWAYS, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except per share data)

     
    Three Months EndedSix Months Ended
    June 30,June 30,
    2014201320142013
     
    Revenues $ 180,613 $ 162,270 $ 357,391 $ 327,435
    Cost of services (exclusive of depreciation and amortization of $9,604, $8,886, $18,976, and $17,712, respectively, included below) 146,476 133,468 294,624 274,726
    Selling, general & administrative expenses 16,899 14,279 33,331 27,377
    Depreciation and amortization 13,536 13,015 26,872 26,548
    Legal settlement charges           9,363      
     
    Operating income (loss) 3,702 1,508 (6,799) (1,216 )
    Interest expense   4,516     3,158     8,899     6,479  
     
    Loss before income taxes (814) (1,650 ) (15,698) (7,695 )
    Income tax benefit   (297)   (549 )   (5,585)   (2,644 )
     
    Net loss $ (517) $ (1,101 ) $ (10,113) $ (5,051 )
     
    Loss per share:
    Basic $ (0.01) $ (0.03 ) $ (0.29) $ (0.15 )
     
    Diluted (1) $ (0.01) $ (0.03 ) $ (0.29) $ (0.15 )
     
    Comprehensive loss $ (449) $ (1,136 ) $ (9,702) $ (4,888 )
     

    Weighted average common shares and equivalents:

    Basic 35,285 34,188 35,219 34,089
    Diluted (1)35,285 34,188 35,219 34,089
     

    (1) The assumed exercise of stock-based compensation awards for the three and six months ended June 30, 2014 and 2013 was not considered because the impact would be anti-dilutive.

     
           

    HEALTHWAYS, INC.

    CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands)

     

    ASSETS

     
    June 30,

    December 31,

    2014

    2013

    Current assets:
    Cash and cash equivalents $ 2,427 $ 2,584
    Accounts receivable, net 108,715 89,484
    Prepaid expenses 9,873 9,228
    Other current assets 7,694 6,857
    Income taxes receivable 5,465 1,402
    Deferred tax asset   8,562     9,667  
    Total current assets 142,736 119,222
     
    Property and equipment:
    Leasehold improvements 38,143 37,463
    Computer equipment and related software 305,482 290,392
    Furniture and office equipment 23,230 22,881
    Capital projects in process   35,618     25,228  
    402,473 375,964
    Less accumulated depreciation   (238,949)   (217,766 )
    163,524 158,198
     
    Other assets 63,886 53,629
    Intangible assets, net 74,029 79,162
    Goodwill, net   338,800     338,800  
     
    Total assets $ 782,975   $ 749,011  
     
           

    HEALTHWAYS, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)

     

    LIABILITIES AND STOCKHOLDERS’ EQUITY

     
    June 30,December 31,
    20142013
    Current liabilities:
    Accounts payable $ 42,206 $ 33,125
    Accrued salaries and benefits 17,325 20,157
    Accrued liabilities 47,767 32,065
    Deferred revenue 6,717 4,496
    Contract billings in excess of earned revenue 23,783 17,411
    Current portion of long-term debt 18,533 14,340
    Current portion of long-term liabilities   784     2,822  
    Total current liabilities 157,115 124,416
     
    Long-term debt 234,224 237,582
    Long-term deferred tax liability 28,971 33,320
    Other long-term liabilities 64,775 51,003
     
    Stockholders’ equity:
    Preferred stock

    $.001 par value, 5,000,000 shares authorized, none outstanding

    Common stock

    $.001 par value, 120,000,000 shares authorized, 35,334,275 and 35,107,303 shares outstanding, respectively

    35 35
    Additional paid-in capital 288,146 283,244
    Retained earnings 37,887 48,000
    Treasury stock, at cost, 2,254,953 shares in treasury (28,182) (28,182 )
    Accumulated other comprehensive income (loss)   4     (407 )
    Total stockholders’ equity   297,890     302,690  
     
    Total liabilities and stockholders’ equity $ 782,975   $ 749,011  
     
     

    HEALTHWAYS, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

           
    Six Months Ended
    June 30,
    20142013
    Cash flows from operating activities:
    Net loss $(10,113) $ (5,051 )

    Adjustments to reconcile net loss to net cash provided by operating activities, net of business acquisitions:

    Depreciation and amortization 26,872 26,548
    Amortization of deferred loan costs 925 483
    Amortization of debt discount 3,303
    Share-based employee compensation expense 3,558 3,458
    Deferred income taxes (3,332) 500
    Excess tax benefits from share-based payment arrangements (310) (231 )
    (Increase) decrease in accounts receivable, net (19,373) 26,613
    Increase in other current assets (940) (3,917 )
    Decrease in accounts payable (3,251) (1,611 )
    Decrease in accrued salaries and benefits (3,489) (8,090 )
    Increase in other current liabilities 17,913 293
    Other   7,548     (96 )
    Net cash flows provided by operating activities   19,311     38,899  
     
    Cash flows from investing activities:
    Acquisition of property and equipment (20,976) (19,579 )
    Business acquisitions, net of cash acquired (830 )
    Other   (3,829)   (3,843 )
    Net cash flows used in investing activities   (24,805)   (24,252 )
     
    Cash flows from financing activities:
    Proceeds from issuance of long-term debt 224,900 228,625
    Payments of long-term debt (233,554) (254,252 )
    Deferred loan costs (88) (1,180 )
    Excess tax benefits from share-based payment arrangements 310 231
    Exercise of stock options 1,265 2,164
    Change in outstanding checks and other   12,114     11,366  
    Net cash flows provided by (used in) financing activities   4,947     (13,046 )
     
    Effect of exchange rate changes on cash   390     (1,109 )
     
    Net (decrease) increase in cash and cash equivalents   (157)   492  
     
    Cash and cash equivalents, beginning of period   2,584     1,759  
     
    Cash and cash equivalents, end of period $2,427   $ 2,251  
     
     

    HEALTHWAYS, INC.

    RECONCILIATION OF NON-GAAP MEASURES TO GAAP MEASURES

    (Unaudited)

     

    Reconciliation of Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share

    to Net Loss and Net Loss Per Share, GAAP Basis

                                   

    Three Months Ended

    June 30, 2014

    Three Months Ended

    June 30, 2013

    Six Months Ended

    June 30, 2014

    Six Months Ended

    June 30, 2013

    $ in

    thousands

    Per Share

    $ in

    thousands

    Per Share

    $ in

    thousands

    Per Share

    $ in

    thousands

    Per Share
    Adjusted net income (loss) (1) $ 494 $ 0.01 $ (1,101 ) $ (0.03 ) $ (2,079 ) $

    (0.06


    )
    $ (5,051 ) $ (0.15 )
    Net loss attributable to non-cash interest charges (2) (1,011 ) (0.03 ) (1,997 ) (0.06 )
    Net loss attributable to legal settlement charges (3)                   (6,037 )   (0.17 )        
    Net loss, GAAP basis (4) $ (517 ) $ (0.01 ) $ (1,101 ) $ (0.03 ) $ (10,113 ) $ (0.29 ) $ (5,051 ) $ (0.15 )
     

    (1) Adjusted net income (loss) and adjusted net income (loss) per share are non-GAAP financial measures. The Company excludes net loss attributable to non-cash interest and legal settlement charges from these measures because of their comparability to the Company’s historical operating results. The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management. You should not consider adjusted net income (loss) or adjusted net income (loss) per share in isolation or as a substitute for net loss or net loss per share determined in accordance with accounting principles generally accepted in the United States.

    (2) Net loss attributable to non-cash interest charges represents the after-tax impact of the amortization of a debt discount for the three and six months ended June 30, 2014.

    (3) Net loss attributable to legal settlement charges represents the after-tax impact of the Company’s settlement of a contractual dispute in April 2014.

    (4) Figures may not add due to rounding.

     

    Reconciliation of Adjusted EPS Guidance

    to EPS Guidance, GAAP Basis

     
        Twelve Months Ending
    December 31, 2014
    Adjusted EPS guidance (5) $ 0.11-0.26
    EPS (loss) guidance attributable to non-cash interest charges (6) (0.11 )
    EPS (loss) guidance attributable to legal settlement charges (7)   (0.17 )
    EPS (loss) guidance, GAAP basis $

    (0.17)-(0.02

    )

     

    (5) Adjusted EPS guidance is a non-GAAP financial measure. The Company excludes EPS (loss) guidance attributable to non-cash interest and legal settlement charges from this measure because of its comparability to the Company’s historical operating results. The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management. You should not consider adjusted EPS guidance in isolation or as a substitute for EPS (loss) guidance determined in accordance with accounting principles generally accepted in the United States.

    (6) EPS (loss) guidance attributable to non-cash interest charges consists of pre-tax charges of $6.8 million for the twelve months ending December 31, 2014 associated with amortization of a debt discount.

    (7) EPS (loss) guidance attributable to legal settlement charges consists of pre-tax charges of $9.4 million for the twelve months ending December 31, 2014 related to the Company’s settlement of a contractual dispute in April 2014.

     

    Reconciliation of Adjusted EBITDA

    to Net Loss, GAAP Basis

    (In thousands)

     
        Six Months Ended    

    Six Months Ended

       
    June 30, 2014June 30, 2013Growth
    Adjusted EBITDA (8)$29,436 $ 25,332 16 %
    Legal settlement charges (9)(9,363)
    Depreciation and amortization (26,872) (26,548 )
    Interest expense (8,899) (6,479 )
    Income tax benefit   5,585     2,644  
    Net loss, GAAP basis $(10,113)   (5,051 )
     

    (8) Adjusted EBITDA is a non-GAAP financial measure. The Company excludes legal settlement charges from this measure because of its comparability to the Company’s historical operating results. The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management. You should not consider adjusted EBITDA in isolation or as a substitute for net loss determined in accordance with accounting principles generally accepted in the United States.

    (9) Legal settlement charges consists of pre-tax charges of $9.4 million for the six months ended June 30, 2014 related to the Company’s settlement of a contractual dispute in April 2014.



    Healthways

    Chip Wochomurka, 615-614-4493

    chip.wochomurka@healthways.com

    Source: Healthways


  • For more stories on investments and markets, please see HispanicBusiness' Finance Channel



    Source: Business Wire


    Story Tools






    HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters